319 related articles for article (PubMed ID: 26940275)
21. [Germ line predisposition for myeloid neoplasia in adults].
Nitschke NJ; Andersen MK; Grønbæk K
Ugeskr Laeger; 2021 Oct; 183(42):. PubMed ID: 34709158
[TBL] [Abstract][Full Text] [Related]
22. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
Obiorah IE; Upadhyaya KD; Calvo KR
Clin Lab Med; 2023 Dec; 43(4):615-638. PubMed ID: 37865507
[TBL] [Abstract][Full Text] [Related]
23. Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.
Akpan IJ; Osman AEG; Drazer MW; Godley LA
Curr Hematol Malig Rep; 2018 Dec; 13(6):426-434. PubMed ID: 30259338
[TBL] [Abstract][Full Text] [Related]
24. Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
Klco JM; Mullighan CG
Nat Rev Cancer; 2021 Feb; 21(2):122-137. PubMed ID: 33328584
[TBL] [Abstract][Full Text] [Related]
25. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
26. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
27. Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia.
Li R; Sobreira N; Witmer PD; Pratz KW; Braunstein EM
Haematologica; 2016 Jun; 101(6):e228-31. PubMed ID: 26944477
[No Abstract] [Full Text] [Related]
28. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
West AH; Godley LA; Churpek JE
Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820
[TBL] [Abstract][Full Text] [Related]
29. Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis.
Reinig EF; Rubinstein JD; Patil AT; Schussman AL; Horner VL; Kanagal-Shamanna R; Churpek JE; Matson DR
Leukemia; 2023 Aug; 37(8):1589-1599. PubMed ID: 37393344
[TBL] [Abstract][Full Text] [Related]
30. Implications of the 5
Lee C; Kim HN; Kwon JA; Yoon SY; Jeon MJ; Yu ES; Kim DS; Choi CW; Yoon J
Ann Lab Med; 2023 Sep; 43(5):503-507. PubMed ID: 37080752
[TBL] [Abstract][Full Text] [Related]
31. Genetic predisposition to MDS: diagnosis and management.
Furutani E; Shimamura A
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):110-119. PubMed ID: 31808839
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
Patel U; Luthra R; Medeiros LJ; Patel KP
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
[TBL] [Abstract][Full Text] [Related]
33. Recurrent mutations in multiple components of the SWI/SNF complex in myelodysplastic syndromes and acute myeloid leukaemia.
Yao H; Huo L; Ping N; Liu H; Li H; Ding Z; Shen H; Xie J; Qiu Q; Ma L; Jiang A; Wang Q; Wu D; Yang X; Song Y; Chen S
Br J Haematol; 2022 Jan; 196(2):441-444. PubMed ID: 34535894
[No Abstract] [Full Text] [Related]
34. Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications.
Liu YC; Geyer JT
Pathobiology; 2024; 91(1):30-44. PubMed ID: 37311434
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
Falini B; Martelli MP
Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
[TBL] [Abstract][Full Text] [Related]
36. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract][Full Text] [Related]
37. Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).
Hasserjian RP; Kelley TW; Weinberg OK; Morgan EA; Fend F
Am J Clin Pathol; 2019 Aug; 152(3):302-321. PubMed ID: 31263893
[TBL] [Abstract][Full Text] [Related]
38. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
[TBL] [Abstract][Full Text] [Related]
39. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
Kohlmann A; Bacher U; Schnittger S; Haferlach T
Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
[TBL] [Abstract][Full Text] [Related]
40. Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL; Hahn CN; Scott HS
Blood; 2020 Jul; 136(1):24-35. PubMed ID: 32430494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
